PerkinElmer launches free COVID-19 data dashboards

By The Science Advisory Board staff writers

July 22, 2020 -- PerkinElmer has launched two free, open access COVID-19 data dashboards to speed up the discovery of antivirals and vaccines for the infection.

PerkinElmer's COVID-19 drug compound dashboard allows scientists to narrow down the 1.6 million drug compounds that are publicly available by querying a curated chemical substance dataset and related activity data.

Its COVID-19 clinical trial dashboard collects data from sources like the U.S. National Library of Medicine's clinicaltrials.gov. It provides access to trial status, drug compounds being studied, and use of live or dead virus, antibody, antiviral, or DNA-based vaccine approaches.


Copyright © 2020 scienceboard.net
 


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.